Orbit comprises articulating and rotating discectomy instrumentation that employs a minimal, posterior incision and/or MIS tubular approach to remove disc tissue while preparing endplates for fusion.
Luna XD allows an ALIF-sized, circular implant to be delivered to the intervertebral space through a posterior, minimally-invasive access point. Once inserted, the Luna XD implant first expands horizontally to cover the disc footprint.
Luna XD and Orbit are integrated within Spinal Elements’ MIS Ultra™ product and procedure platform.
Jason Blain, CEO of Spinal Elements, said, “The acquisition and integration of the Luna XD and Orbit technologies into the Spinal Elements MIS Ultra portfolio allows Spinal Elements to continue to deliver innovative and clinically-differentiated technologies… Both of these technologies further our goal of being a driving force that fundamentally changes the way spine surgeons approach and operate in minimally-invasive spinal procedures. I am proud of the execution success our team showed in quickly returning these technologies to market.”
Orbit comprises articulating and rotating discectomy instrumentation that employs a minimal, posterior incision and/or MIS tubular approach to remove disc tissue while preparing endplates for fusion.
Luna XD allows an ALIF-sized, circular implant to be delivered to the intervertebral space through a posterior, minimally-invasive access point. Once inserted, the Luna XD implant first expands horizontally to cover the disc footprint.
Luna XD and Orbit are integrated within Spinal Elements’ MIS Ultra™ product and procedure platform.
Jason Blain, CEO of Spinal Elements, said, “The acquisition and integration of the Luna XD and Orbit technologies into the Spinal Elements MIS Ultra portfolio allows Spinal Elements to continue to deliver innovative and clinically-differentiated technologies… Both of these technologies further our goal of being a driving force that fundamentally changes the way spine surgeons approach and operate in minimally-invasive spinal procedures. I am proud of the execution success our team showed in quickly returning these technologies to market.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
